首页> 外文期刊>Clinical and vaccine immunology: CVI >A DNA-Based Candidate HIV Vaccine Delivered via In Vivo Electroporation Induces CD4 Responses toward the α4β7-Binding V2 Loop of HIV gp120 in Healthy Volunteers
【24h】

A DNA-Based Candidate HIV Vaccine Delivered via In Vivo Electroporation Induces CD4 Responses toward the α4β7-Binding V2 Loop of HIV gp120 in Healthy Volunteers

机译:通过体内电穿孔递送的基于DNA的候选HIV疫苗在健康志愿者中诱导针对HIV gp120的α4β7结合V2环的CD4反应。

获取原文
           

摘要

Administration of a clade C/B′ candidate HIV-1 DNA vaccine, ADVAX, by in vivo electroporation (EP) was safe and more immunogenic than intramuscular administration without EP. The breadth and specificity of T-cell responses to full-length Env were mapped. Responses to multiple Env regions were induced, with most focusing on V3/C4 and V2 regions, including the α4β7 integrin-binding domain. The breadth of responses induced by this DNA vaccine regimen was comparable to that of viral-vectored vaccine regimens.
机译:通过体内电穿孔(EP)施用C / B'候选HIV-1 DNA进化枝疫苗ADVAX,与不使用EP的肌肉内施用相比,安全性和免疫原性更高。绘制了T细胞对全长Env应答的广度和特异性。诱导了对多个Env区域的应答,其中大多数集中在V3 / C4和V2区域,包括α4β7整联蛋白结合结构域。这种DNA疫苗方案诱导的反应广度与病毒载体疫苗方案相当。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号